Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders.

about

Editing the genome of hiPSC with CRISPR/Cas9: disease models.The functional genomics laboratory: functional validation of genetic variants.

P2860

Q38711908-4983A58F-EA42-4E49-943F-E9638F48C8A5 Q49991801-7462D28D-EBD4-4F66-A16D-F164B590659C

P2860

Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders.

Item

http://www.wikidata.org/entity/Q48449614

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Genetic and pharmacological co ...... with BH4 metabolism disorders.

@en

Genetic and pharmacological co ...... with BH4 metabolism disorders.

@nl

type

Item

label

Genetic and pharmacological co ...... with BH4 metabolism disorders.

@en

Genetic and pharmacological co ...... with BH4 metabolism disorders.

@nl

prefLabel

Genetic and pharmacological co ...... with BH4 metabolism disorders.

@en

Genetic and pharmacological co ...... with BH4 metabolism disorders.

@nl

P1476

Genetic and pharmacological co ...... with BH4 metabolism disorders.

@en

P2093

Haruhisa Inoue

http://www.w3.org/2001/XMLSchema#string

Jun Takahashi

http://www.w3.org/2001/XMLSchema#string

Keiko Imamura

http://www.w3.org/2001/XMLSchema#string

Mahoko Furujo

http://www.w3.org/2001/XMLSchema#string

Masako Kinoshita

http://www.w3.org/2001/XMLSchema#string

Ryosuke Takahashi

http://www.w3.org/2001/XMLSchema#string

Taizo Ishikawa

http://www.w3.org/2001/XMLSchema#string

Takayuki Kondo

http://www.w3.org/2001/XMLSchema#string

Tomoko Oeda

http://www.w3.org/2001/XMLSchema#string

Yasushi Koshiba

http://www.w3.org/2001/XMLSchema#string

P2860

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress

Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.

Tetrahydrobiopterin biosynthesis, regeneration and functions

Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia.

Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system

Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.

iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease

Disorders of biopterin metabolism

Dihydropteridine reductase deficiency in man: from biology to treatment

P304

5188-5197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDW339

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiroshi Ichinose

Satoshi Hara

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27798097

http://www.w3.org/2001/XMLSchema#string

P932

5886044

http://www.w3.org/2001/XMLSchema#string

Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders.

about

P2860

P2860

Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932